| Literature DB >> 36271046 |
Hui Yang1, Yurui Dong1, Ying Bian1, Nuo Xu1, Yuwei Wu1, Fan Yang1, Yinping Du1, Tao Qin1,2,3,4, Sujuan Chen5,6,7,8, Daxin Peng9,10,11,12, Xiufan Liu1,2,3,4.
Abstract
Influenza A virus (IAV) polymerase protein PB2 has been shown to partially inhibit the host immune response by blocking the induction of interferons (IFNs). However, the IAV PB2 protein that regulates the downstream signaling pathway of IFNs is not well characterized. Here, we report that IAV PB2 protein reduces cellular sensitivity to IFNs, suppressing the activation of STAT1/STAT2 and ISGs. Furthermore, IAV PB2 protein targets mammalian JAK1 at lysine 859 and 860 for ubiquitination and degradation. Notably, the H5 subtype of highly pathogenic avian influenza virus with I283M/K526R mutations on PB2 increases the ability to degrade mammalian JAK1 and exhibits higher replicate efficiency in mammalian (but not avian) cells and mouse lung tissues, and causes greater mortality in infected mice. Altogether, these data describe a negative regulatory mechanism involving PB2-JAK1 and provide insights into an evasion strategy from host antiviral immunity employed by IAV.Entities:
Year: 2022 PMID: 36271046 DOI: 10.1038/s41467-022-33909-2
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694